Straight answers, no hype.

Three steps. You complete a confidential health assessment and baseline labs; a licensed provider reviews everything and decides whether therapy is appropriate and, if so, what to prescribe; and if a therapy is prescribed, it's compounded or dispensed by a licensed U.S. pharmacy and shipped to you with guidance and ongoing monitoring.

Nothing is sold off a shelf. A provider is part of every plan from start to finish.

No. Taking the assessment places no order and carries no obligation. If a provider determines therapy isn't right for you, nothing is prescribed — and you're never charged for a medication you haven't been prescribed.

A licensed clinician reviews your information and makes every prescribing decision. Relyfe is a telehealth and brand platform — it is not a pharmacy or a medical group and does not itself prescribe or dispense. Prescribing is always an independent clinical decision made by a licensed provider.

Timing depends on your labs and provider review. You'll be guided through each step — assessment, labs, provider review, and (if prescribed) fulfillment — with status along the way. We don't promise a specific turnaround, because a real clinical review takes the time it takes.

The therapies available through Relyfe are prescription medications prescribed by licensed clinicians and dispensed by licensed U.S. pharmacies, operating under applicable state and federal law and compounding regulations. Availability of specific therapies depends on your state, provider judgment, and regulatory status, and can change.

Some compounds (see "Peptides coming") are under FDA review and are not sold — they're offered only through an early-access list, which is not an offer to sell.

No — and that difference is the entire point. "Research only" products sold without a prescription can be mislabeled, under-dosed, or contaminated, and using them carries real risk. Supervised care through licensed pharmacies exists specifically to remove that risk. Relyfe does not sell or facilitate gray-market products.

Peptides and hormones are powerful medications, which is exactly why provider supervision isn't optional here. Like any medication they carry potential side effects, and individual suitability varies. Your provider weighs the risks and benefits for you specifically, sets your protocol, and monitors you over time.

No. We don't promise cures or specific outcomes, and nothing on this site is medical advice. Peptides and hormone therapies are studied across recovery, metabolic, and longevity research; the science is promising and still evolving. Whether any therapy is right for you is decided with your provider after a real evaluation.

Subject to provider judgment and your state, the currently available peptide and recovery-adjacent therapies include Sermorelin, Tesamorelin, NAD+, Glutathione, and PT-141, among others. Our Peptide Education Library explains what each is studied for and what to expect.

Doses and pricing aren't shown publicly by design — your provider sets your protocol.

Depending on the therapy: injectable, oral (capsule/troche), or nasal. Each route has trade-offs in absorption, convenience, and comfort. Our Delivery & Safety guide compares them.

These are among several recovery peptides under FDA review in 2026. In April 2026, HHS moved a group of peptides toward consideration for the pathway that would allow licensed compounding, and a Pharmacy Compounding Advisory Committee (PCAC) review is scheduled for July 23–24, 2026.

Until that process completes and any required FDA rulemaking follows, these compounds are not sold here. A favorable July review is a step on the runway, not a launch date.

Yes. Joining early access means you hear first if and when these compounds become legally available through licensed providers. Joining places no order, costs nothing, and is not an offer to sell or a promise that any compound will become available.

Because doing it right matters more than doing it first. Selling compounds that are still under federal review — or sourcing them gray-market to fill the gap — is exactly the risk supervised care is built to avoid. We'd rather you trust what arrives in your hands.

Compounded GLP-1 availability is tied to drug-shortage status, which is changing in 2026 as supply normalizes — the regulatory window for compounded versions is narrowing. Availability and pricing can shift quickly. Whether a GLP-1 is appropriate for you, and which form, is a provider decision. See our GLP-1 guide for what to expect.

Provider-supervised testosterone therapy and related support, prescribed and monitored against your bloodwork. Options a provider may consider include testosterone in several forms, plus supporting therapies — all decided by the clinician based on your labs and goals, never selected off a menu by you.

Yes, testosterone is a controlled substance, which means stricter prescribing rules and state-by-state availability for certain forms. A live clinical evaluation is required, and some states limit telehealth prescribing of certain forms. Your eligibility is confirmed during intake before anything proceeds.

Hormone therapy can affect fertility, and this is exactly the kind of thing to discuss with your provider before starting. Fertility-supportive options exist and may be considered depending on your situation and clinical judgment. This is a conversation for your clinical evaluation, not a decision to make from a website.

Bioidentical hormone support personalized to your labs and goals, with ongoing clinical oversight — studied in the context of sleep, mood, energy, and metabolic wellbeing. As with everything here, what's appropriate is determined by your provider after evaluation.

That's a personal, clinical question that depends on your health history, labs, and goals — which is why it's decided with a licensed provider, not predetermined. The assessment is the place to start that conversation with no obligation to proceed.

Relyfe's pharmacy network ships nationwide, but availability of specific therapies varies by state because it depends on each pharmacy's licensing and on state telehealth prescribing rules. Most therapies are available in most states; some — particularly certain compounded injectables — have state exclusions.

State coverage is set by pharmacy licensing and regulations, which change over time. The intake process is the source of truth for what's available to you right now.

If a specific therapy isn't available in your state, intake will surface that before any charge, and a provider may be able to discuss alternatives that are available to you. No charge is made for something that can't be fulfilled where you live.

Membership covers access and care coordination and is billed on the schedule you choose. Medication is billed separately, per fulfillment, and only after a licensed provider prescribes it. You're never charged for a therapy you haven't been prescribed. Specific medication pricing is shown after the consult, because it depends on what (if anything) your provider prescribes.

Members pay lower per-protocol and per-lab pricing and get added care coordination; non-members can purchase individual protocols, labs, or consults at à la carte rates. Membership is access and savings — it is never a guarantee of a prescription.

Yes. You can cancel your membership at any time; cancellation takes effect at the end of your current billing period. Prescription medications already dispensed can't be returned or refunded, consistent with pharmacy law. Full terms are in our Terms of Service.

Most compounded and optimization therapies in this category are typically paid out of pocket and not covered by insurance. Assume self-pay unless told otherwise during your care.

That depends on the therapy and is a conversation to have with your provider rather than a decision to make abruptly on your own. Some therapies have considerations when discontinuing; your provider can guide a plan. Don't stop or change a prescribed therapy without talking to your clinician.

Your health information is shared only with the people and partners involved in your care — your provider, the dispensing pharmacy, and the labs — and the vendors that operate the platform under confidentiality and data-protection obligations. We don't sell your personal information, and we don't share health information for third-party advertising. Details are in our Privacy Policy.

The platform is HIPAA-aligned, with encryption and multi-factor authentication protecting your information, and protected health information is handled under the appropriate agreements with the licensed providers and pharmacies involved in your care.